These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28824361)

  • 1. Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants.
    Wilks SJ; Hara SA; Ross EK; Nicolai EN; Pignato PA; Cates AW; Ludwig KA
    Front Neurosci; 2017; 11():438. PubMed ID: 28824361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
    Hoppe UC; Brandt MC; Wachter R; Beige J; Rump LC; Kroon AA; Cates AW; Lovett EG; Haller H
    J Am Soc Hypertens; 2012; 6(4):270-6. PubMed ID: 22694986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implant-Mediated Therapy of Arterial Hypertension.
    Gierthmuehlen M; Plachta DTT; Zentner J
    Curr Hypertens Rep; 2020 Feb; 22(2):16. PubMed ID: 32030509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension.
    Wallbach M; Böhning E; Lehnig LY; Schroer C; Müller GA; Wachter R; Lüders S; Zenker D; Koziolek MJ
    J Hypertens; 2018 Aug; 36(8):1762-1769. PubMed ID: 29677053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies.
    Madershahian N; Scherner M; Müller-Ehmsen J; Halbach M; Hickethier T; Velden R; Choi YH; Wippermann J; Wahlers T
    Europace; 2014 Jun; 16(6):861-5. PubMed ID: 24525551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid baroreflex activation therapy for resistant hypertension.
    Victor RG
    Nat Rev Cardiol; 2015 Aug; 12(8):451-63. PubMed ID: 26149485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.
    Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C
    BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical carotid baroreceptor stimulation.
    Schmidli J; von Allmen RS; Mohaupt MG
    Wien Med Wochenschr; 2014 Dec; 164(23-24):508-14. PubMed ID: 25411011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasoft microwire neural electrodes improve chronic tissue integration.
    Du ZJ; Kolarcik CL; Kozai TDY; Luebben SD; Sapp SA; Zheng XS; Nabity JA; Cui XT
    Acta Biomater; 2017 Apr; 53():46-58. PubMed ID: 28185910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
    Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review.
    Courand PY; Feugier P; Workineh S; Harbaoui B; Bricca G; Lantelme P
    Arch Cardiovasc Dis; 2014 Dec; 107(12):690-6. PubMed ID: 25445751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
    Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic electrical stimulation of the auditory nerve at high stimulus rates: a physiological and histopathological study.
    Xu J; Shepherd RK; Millard RE; Clark GM
    Hear Res; 1997 Mar; 105(1-2):1-29. PubMed ID: 9083801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
    Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
    Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic electrical stimulation of the auditory nerve using high surface area (HiQ) platinum electrodes.
    Tykocinski M; Duan Y; Tabor B; Cowan RS
    Hear Res; 2001 Sep; 159(1-2):53-68. PubMed ID: 11520634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of baroreceptor activation therapy in chronic heart failure: a case report.
    Wang D; Veltmann C; Bauersachs J; Duncker D
    Eur Heart J Case Rep; 2023 Nov; 7(11):ytad520. PubMed ID: 37954563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term performance of porous platinum coated neural electrodes.
    Leber M; Bhandari R; Mize J; Warren DJ; Shandhi MMH; Solzbacher F; Negi S
    Biomed Microdevices; 2017 Sep; 19(3):62. PubMed ID: 28688070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
    Wallbach M; Koziolek MJ; Wachter R
    Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology.
    Sanchez LA; Illig K; Levy M; Trachiotis G; Shanley C; Irwin E; Jim J; Rossing M; Kieval R
    Ann Vasc Surg; 2010 Feb; 24(2):178-84. PubMed ID: 20036504
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.